Pathstone Holdings’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$932K Buy
9,765
+222
+2% +$21.3K ﹤0.01% 1538
2026
Q1
$989K Buy
9,543
+1,611
+20% +$183K ﹤0.01% 1414
2025
Q4
$800K Sell
7,932
-2,634
-25% -$286K ﹤0.01% 1532
2025
Q3
$1.3M Sell
10,566
-1,554
-13% -$193K 0.01% 1268
2025
Q2
$1.46M Sell
12,120
-724
-6% -$96.6K 0.01% 1184
2025
Q1
$1.89M Sell
12,844
-632
-5% -$96.5K 0.01% 1021
2024
Q4
$2.19M Buy
13,476
+436
+3% +$71.3K 0.01% 922
2024
Q3
$2.12M Sell
13,040
-427
-3% -$63.3K 0.01% 940
2024
Q2
$1.84M Buy
13,467
+925
+7% +$128K 0.01% 967
2024
Q1
$1.92M Sell
12,542
-1,021
-8% -$152K 0.01% 925
2023
Q4
$1.93M Buy
+13,563
New +$1.81M 0.01% 756

Other funds holding CLX

Pathstone Holdings's CLX Position: Q2 2026 in Review

Pathstone Holdings increased its Clorox (CLX) stake by 2.3% in Q2 2026, buying an estimated $21.3K and bringing the position to 9,765 shares worth $932K. The position accounts for ﹤0.01% of the portfolio, ranked #1538.

Pathstone Holdings first reported a position in CLX in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.19M in Q4 2024. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Pathstone Holdings held 9,765 shares of Clorox worth $932K as of Q2 2026.
  • Pathstone Holdings bought 222 Clorox shares in Q2 2026, an estimated $21.3K.
  • Clorox made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1538 holding.
  • Pathstone Holdings first reported a position in Clorox in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Clorox position peaked at $2.19M in Q4 2024.
  • 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.